Clinical Trials on Unilateral in Poland

Total 10 results

Novartis Pharmaceuticals

Completed

Safety, Tolerability and Efficacy for CGF166 in Patients With Unilateral or Bilateral Severe-to-profound Hearing Loss

Unilateral Severe to Profound Hearing Loss OR Bilateral Severe to Profound Hearing Loss

United States
Bruno Vision Care

Completed

Study to Evaluate the Clinical Performance of Deseyne (Vifilcon C) Daily Disposable Soft Contact Lens

Refractive Error - Myopia Bilateral

United States
Radboud University Medical Center

Recruiting

Societal Merit of Intervention on Hearing Loss Evaluation (SMILE)

Hearing Loss, Sensorineural | Hearing Loss, Bilateral | Hearing Loss, Adult-Onset | Hearing Loss, Bilateral Sensorineural, Progressive

Netherlands
Jagiellonian University

Recruiting

Subclinical Hypothyroidism and Chronic Inflammation in PCOS

Subclinical hypothyroïdism | PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries | Hypothalamic-Pituitary-Gonadal Axis Dysfunction

Poland
Amsterdam UMC, location VUmc

Recruiting

Trilateral Retinoblastoma: Incidence and Outcomes (GS-TRIO)

Retinoblastoma | Trilateral Retinoblastoma

Netherlands
Smith & Nephew, Inc.

Active, not recruiting

JOURNEY II XR Safety and Effectiveness PMCF

Knee Osteoarthritis | Rheumatoid Vasculitis With Rheumatoid Arthritis of Knee | Unilateral Post-Traumatic Osteoarthritis of Knee | Degenerative Arthritis Peripheral Joint | Failed Osteotomies | Failed Unicompartmental Replacement

United States
OHSU Knight Cancer Institute
Eli Lilly and Company; GlaxoSmithKline; Oregon Health and Science University

Active, not recruiting

Abemaciclib and Niraparib Before Surgery for the Treatment of Hormone Receptor Positive HER2 Negative Breast Cancer

Anatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage IA Breast Cancer AJCC v8 | Anatomic Stage IB Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage IIIA Breast Cancer AJCC v8 | Prognostic... and other conditions

United States
Optinose US Inc.

Completed

Study Evaluating the Efficacy and Safety of Intranasal Administration of 100, 200, and 400 μg of Fluticasone Propionate Twice a Day (BID) Using a Novel Bi Directional Device in Subjects With Bilateral Nasal Polyposis Followed by an 8-Week Open-Label Extension Phase to Assess Safety

Bilateral Nasal Polyposis

United States, Canada
National Cancer Institute (NCI)

Active, not recruiting

Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer

Breast Ductal Carcinoma In Situ | Invasive Breast Carcinoma | Multicentric Breast Carcinoma | Multifocal Breast Carcinoma | Synchronous Bilateral Breast Carcinoma

United States, France, Spain, Canada, Saudi Arabia, Puerto Rico, Korea, Republic of, Ireland, Colombia, Mexico
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI); Seagen Inc.

Recruiting

T-DM1 and Tucatinib Compared With T-DM1 Alone in Preventing Relapses in People With High Risk HER2-Positive Breast Cancer, the CompassHER2 RD Trial

Anatomic Stage IA Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IIIA Breast Cancer AJCC v8 | Anatomic Stage IIIB Breast Cancer AJCC... and other conditions

United States, Canada, Puerto Rico

Clinical Trials on Unilateral in Poland

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bosnia & Herzegovina

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations